Prospera Financial Services’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$333K Sell
4,194
-147
-3% -$11.1K ﹤0.01% 1201
2026
Q1
$326K Sell
4,341
-418
-9% -$33K 0.01% 1180
2025
Q4
$376K Buy
4,759
+178
+4% +$13.4K 0.01% 1048
2025
Q3
$300K Buy
+4,581
New +$224K 0.01% 1138
2024
Q3
Sell
-4,451
Closed -$212K 1160
2024
Q2
$212K Sell
4,451
-166
-4% -$6.81K 0.01% 1053
2024
Q1
$200K Sell
4,617
-81
-2% -$3.86K 0.01% 1043
2023
Q4
$238K Sell
4,698
-55
-1% -$2.63K 0.01% 933
2023
Q3
$216K Buy
+4,753
New +$196K 0.01% 927
2022
Q4
Sell
-5,095
Closed -$226K 929
2022
Q3
$226K Sell
5,095
-26,189
-84% -$1.1M 0.01% 741
2022
Q2
$1.16M Buy
31,284
+26,644
+574% +$1M 0.06% 336
2022
Q1
$172K Buy
+4,640
New +$152K 0.01% 927
2020
Q4
Sell
-177
Closed -$8K 1102
2020
Q3
$8K Sell
177
-4,924
-97% -$274K ﹤0.01% 1169
2020
Q2
$301K Sell
5,101
-2,749
-35% -$153K 0.03% 440
2020
Q1
$371K Sell
7,850
-1,244
-14% -$69.3K 0.04% 366
2019
Q4
$549K Buy
9,094
+1,134
+14% +$67.6K 0.04% 365
2019
Q3
$477K Buy
+7,960
New +$519K 0.05% 318

Other funds holding IONS